LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.
LeMaitre Vascular Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$53.58|
|52 Week High||US$31.21|
|52 Week Low||US$64.50|
|1 Month Change||-7.86%|
|3 Month Change||-2.60%|
|1 Year Change||65.83%|
|3 Year Change||91.02%|
|5 Year Change||169.65%|
|Change since IPO||764.19%|
Recent News & Updates
With EPS Growth And More, LeMaitre Vascular (NASDAQ:LMAT) Is Interesting
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
LeMaitre Vascular, Inc. ( NASDAQ:LMAT ), is not the largest company out there, but it led the NASDAQGM gainers with a...
We Think LeMaitre Vascular (NASDAQ:LMAT) Can Manage Its Debt With Ease
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
|LMAT||US Medical Equipment||US Market|
Return vs Industry: LMAT exceeded the US Medical Equipment industry which returned 20% over the past year.
Return vs Market: LMAT exceeded the US Market which returned 27.6% over the past year.
Stable Share Price: LMAT is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: LMAT's weekly volatility (3%) has been stable over the past year.
About the Company
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient’s body, and allows them to locate tributaries or lesions beneath the skin.
LeMaitre Vascular Fundamentals Summary
|LMAT fundamental statistics|
Is LMAT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|LMAT income statement (TTM)|
|Cost of Revenue||US$52.85m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Oct 28, 2021
|Earnings per share (EPS)||1.32|
|Net Profit Margin||19.12%|
How did LMAT perform over the long term?See historical performance and comparison
0.8%Current Dividend Yield
Is LeMaitre Vascular undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: LMAT ($53.58) is trading below our estimate of fair value ($59.87)
Significantly Below Fair Value: LMAT is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: LMAT is good value based on its PE Ratio (40.6x) compared to the US Medical Equipment industry average (48.4x).
PE vs Market: LMAT is poor value based on its PE Ratio (40.6x) compared to the US market (18.2x).
Price to Earnings Growth Ratio
PEG Ratio: LMAT is poor value based on its PEG Ratio (3.7x)
Price to Book Ratio
PB vs Industry: LMAT is overvalued based on its PB Ratio (6.3x) compared to the US Medical Equipment industry average (4.3x).
How is LeMaitre Vascular forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LMAT's forecast earnings growth (11% per year) is above the savings rate (2%).
Earnings vs Market: LMAT's earnings (11% per year) are forecast to grow slower than the US market (15.1% per year).
High Growth Earnings: LMAT's earnings are forecast to grow, but not significantly.
Revenue vs Market: LMAT's revenue (6.6% per year) is forecast to grow slower than the US market (9.9% per year).
High Growth Revenue: LMAT's revenue (6.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LMAT's Return on Equity is forecast to be low in 3 years time (12.6%).
How has LeMaitre Vascular performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LMAT has high quality earnings.
Growing Profit Margin: LMAT's current net profit margins (19.1%) are higher than last year (14.4%).
Past Earnings Growth Analysis
Earnings Trend: LMAT's earnings have grown by 13.9% per year over the past 5 years.
Accelerating Growth: LMAT's earnings growth over the past year (74.7%) exceeds its 5-year average (13.9% per year).
Earnings vs Industry: LMAT earnings growth over the past year (74.7%) exceeded the Medical Equipment industry 36.1%.
Return on Equity
High ROE: LMAT's Return on Equity (15.5%) is considered low.
How is LeMaitre Vascular's financial position?
Financial Position Analysis
Short Term Liabilities: LMAT's short term assets ($90.0M) exceed its short term liabilities ($21.5M).
Long Term Liabilities: LMAT's short term assets ($90.0M) exceed its long term liabilities ($39.2M).
Debt to Equity History and Analysis
Debt Level: LMAT's debt to equity ratio (12.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if LMAT's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: LMAT's debt is well covered by operating cash flow (197.1%).
Interest Coverage: LMAT's interest payments on its debt are well covered by EBIT (16.9x coverage).
What is LeMaitre Vascular current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: LMAT's dividend (0.82%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.29%).
High Dividend: LMAT's dividend (0.82%) is low compared to the top 25% of dividend payers in the US market (3.49%).
Stability and Growth of Payments
Stable Dividend: LMAT's dividends per share have been stable in the past 10 years.
Growing Dividend: LMAT's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (29.1%), LMAT's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
George LeMaitre (56 yo)
Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...
CEO Compensation Analysis
Compensation vs Market: George's total compensation ($USD1.39M) is below average for companies of similar size in the US market ($USD2.26M).
Compensation vs Earnings: George's compensation has been consistent with company performance over the past year.
Experienced Management: LMAT's management team is seasoned and experienced (14.3 years average tenure).
Experienced Board: LMAT's board of directors are seasoned and experienced ( 17.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.8%.
LeMaitre Vascular, Inc.'s employee growth, exchange listings and data sources
- Name: LeMaitre Vascular, Inc.
- Ticker: LMAT
- Exchange: NasdaqGM
- Founded: 1983
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$1.169b
- Shares outstanding: 21.81m
- Website: https://www.lemaitre.com
Number of Employees
- LeMaitre Vascular, Inc.
- 63 Second Avenue
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/16 22:19|
|End of Day Share Price||2021/10/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.